SIGN UP
LOG IN
T
TSHA
Taysha Gene Therapies, Inc.
2.34
0.03+1.30%After Hours: 2.400 +0.060 +2.56%18:26 07/01 EDT
OPEN/PREV CLOSE2.350/2.310
TODAY RANGE2.250-2.465
VOL2.68M
MARKET CAP611.98M
52 WEEK RANGE1.050-3.310
AVG VOL (3M)3.72M
% TURNOVER1.02%
TURNOVER--
P/E (TTM)-6.9830
% RANGE9.31%
EPS(TTM)-0.3351
P/E(FORWARD)-7.3125
P/B8.72
BVPS0.2685
DIVIDEND--
P/S57.49
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP540.57M
SHARES OUTSTANDING261.53M
NEXT EARNINGS08/11-08/15
FREE FLOAT231.01M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/20 11:05
Taysha Gene Therapies (TSHA) Gets a Buy from Wells Fargo
TipRanks·06/17 13:16
Craig-Hallum bullish on Neurogene, initiates with a Buy
TipRanks·06/12 11:25
Truist Financial Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)
TipRanks·06/11 14:25
Taysha Gene Therapies price target raised to $13 from $7 at Cantor Fitzgerald
Dow Jones·06/10 10:50
Taysha Gene Therapies Price Target Maintained With a $8.00/Share by Needham
Benzinga·06/10 10:40
Needham Reiterates Buy on Taysha Gene Therapies, Maintains $8 Price Target
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.